CoChat

Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice

Dominguez, Elisa, Marais, Thibaut, Chatauret, Nicolas, Benkhelifa-Ziyyat, Sofia, Duque, Sandra, Ravassard, Philippe, Carcenac, Romain, Astord, Stéphanie, de Moura, Aurélie Pereira, Voit, Thomas, Barkats, Martine · 2011 · Human Molecular Genetics

The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.

Abstract

Spinal muscular atrophy (SMA) is the most common genetic disease leading to infant mortality. This neuromuscular disorder is caused by the loss or mutation of the telomeric copy of the 'survival of motor neuron' (Smn) gene, termed SMN1. Loss of SMN1 leads to reduced SMN protein levels, inducing degeneration of motor neurons (MN) and progressive muscle weakness and atrophy. To date, SMA remains incurable due to the lack of a method to deliver therapeutically active molecules to the spinal cord. Gene therapy, consisting of reintroducing SMN1 in MNs, is an attractive approach for SMA. Here we used postnatal day 1 systemic injection of self-complementary adeno-associated virus (scAAV9) vectors carrying a codon-optimized SMN1 sequence and a chimeric intron placed downstream of the strong phosphoglycerate kinase (PGK) promoter (SMNopti) to overexpress the human SMN protein in a mouse model of severe SMA. Survival analysis showed that this treatment rescued 100% of the mice, increasing life expectancy from 27 to over 340 days (median survival of 199 days) in mice that normally survive about 13 days. The systemic scAAV9 therapy mediated complete correction of motor function, prevented MN death and rescued the weight loss phenotype close to normal. This study reports the most efficient rescue of SMA mice to date after a single intravenous injection of an optimized SMN-encoding scAAV9, highlighting the considerable potential of this method for the treatment of human SMA.

Overview

Integrity signals

Registry

Crossref · 10.1093/hmg/ddq514

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 51 references

Cited by

See all 337

Metadata

Authors
Dominguez, E., Marais, T., Chatauret, N., Benkhelifa-Ziyyat, S., Duque, S., Ravassard, P., Carcenac, R., Astord, S., de Moura, A. P., Voit, T., & Barkats, M.
Affiliations
Centre National de la Recherche Scientifique (FR)
Corresponding author
Barkats, Martine
Venue
Human Molecular Genetics
Published
2010-11-30
Volume
20
Issue
4
Pages
681-693
ISSN
  • 0964-6906 (ISSN-L)
  • 1460-2083
OpenAlex
W2119878613
Cited by
298
References
52
Citations by year
2026: 8 · 2025: 9 · 2024: 11 · 2023: 10 · 2022: 8 · 2021: 17 · 2020: 17 · 2019: 17 · 2018: 15 · 2017: 21 · 2016: 21 · 2015: 31 · 2014: 29 · 2013: 33 · 2012: 23
FWCI
11.95
Type
journal article
Language
en
Open access
closed
Locations
  • Human Molecular Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion)
Funders
  • California Department of Transportation
  • National Science Council
Topics
  • Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
Keywords
spinal muscular atrophy, SMN1, gene therapy, codon optimization, intravenous delivery, motor neuron survival, phosphoglycerate kinase promoter, SMA mouse model
MeSH terms
Dependovirus, Animals, Disease Models, Animal, Female, Genetic Vectors, Humans, Motor Neurons, Muscular Atrophy, Spinal, Phenotype, Spinal Cord, Genetic Therapy, Survival Analysis, Treatment Outcome, Gene Transfer Techniques, Mice, Knockout, Mice, Survival of Motor Neuron 1 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice. https://app.cochat.ai/papers/10.1093/hmg/ddq514
The paper
Dominguez, E., Marais, T., Chatauret, N., Benkhelifa-Ziyyat, S., Duque, S., Ravassard, P., Carcenac, R., Astord, S., de Moura, A. P., Voit, T., & Barkats, M. (2011). Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddq514

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.